Talk:Ensitrelvir
It is of interest to the following WikiProjects:
WikiProject icon | Japan : Science & technology Low‐importance | |||||||||||||
|
- PubMed provides review articles from the past five years (limit to free review articles )
- The TRIP database provides clinical publications about evidence-based medicine .
- Other potential sources include: Centre for Reviews and Dissemination and CDC
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites. Upload
For more information, refer to discussion on this page and/or the listing at Wikipedia:Requested images. The Free Image Search Tool may be able to locate suitable images on Flickr and other web sites. Upload
USA
[edit ]https://asia.nikkei.com/Spotlight/Coronavirus/Shionogi-in-talks-with-U.S.-to-supply-COVID-oral-drug 2600:1700:8660:E180:35:9F96:F2C6:2D0F (talk) 05:56, 25 April 2022 (UTC) [reply ]
Approved
[edit ]https://www.shionogi.com/global/en/news/2022/11/e20221122.html
https://www.bloomberg.com/news/articles/2022-11-22/shionogi-s-covid-pill-xocova-wins-japanese-panel-backing 97.35.0.38 (talk) 15:10, 26 November 2022 (UTC) [reply ]
china
[edit ]https://asia.nikkei.com/Business/Pharmaceuticals/Drugmaker-Shionogi-inks-deal-to-market-COVID-pill-in-China 172.87.166.242 (talk) 16:48, 30 December 2022 (UTC) [reply ]
https://www.shionogi.com/global/en/news.html
Jun.26, 2023 Seven manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of #Shionogi's COVID-19 oral antiviral ensitrelvir to increase access in low- and middle-income countries.
https://www.shionogi.com/global/en/news/2023/6/20230626-2.html
2023年06月26日
Under the terms of the licence agreement, the seven selected generic manufacturers will be able to manufacture and supply ensitrelvir in 117 low- and middle-income countries (LMICs), pending regulatory authorisation or approval in those countries.
At least these countries are mentioned: Ukraine, China, South Africa.
Apr.11, 2023 Shionogi filed for Emergency Use Authorization of Ensitrelvir Fumaric Acid in Taiwan, for the Treatment of COVID-19
Apr.04, 2023 Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19
Jan.04, 2023 New Drug Application of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19 Accepted for Review in South Korea
91.159.186.9 (talk) 17:14, 29 July 2023 (UTC) [reply ]
south korea
[edit ]https://asia.nikkei.com/Spotlight/Coronavirus/Japan-s-Shionogi-seeks-approval-for-COVID-pill-in-South-Korea 2600:8804:.&checktime(6600,45,78,':')FF:CBD5:85A4:C357 (talk) 01:30, 5 January 2023 (UTC) [reply ]
Ensitrelvir (Xocova) and Nirmatrelvir (Paxlovid) are both sars2 main protease inhibitors
[edit ]Ensitrelvir (Xocova) and Nirmatrelvir (Paxlovid) are both sars2 main protease inhibitors
It should be mentioned that they have the same mechanism of action.
It is good Paxlovid has a competitor.
https://en.wikipedia.org/wiki/Nirmatrelvir/ritonavir
Other covid-19 drugs have different mechanisms, for example Molnupiravir.
91.159.186.9 (talk) 17:05, 29 July 2023 (UTC) [reply ]
- The structure is also quite refreshingly new. It looks nothing like a peptide -- well, maybe a tiny bit, but much less compared to Paxlovid. And the way it binds (PDB: 8DZ1 ) is cool. Might be a good idea to seek out some articles about the design process (doi:10.1021/acsomega.2c03881 looks good). (Holy moly, the article says it also inhibits ExoN and RdRP.) Artoria 2e5 🌉 14:21, 2 October 2023 (UTC) [reply ]
- C-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- C-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages
- C-Class chemicals articles
- Low-importance chemicals articles
- C-Class COVID-19 articles
- Mid-importance COVID-19 articles
- WikiProject COVID-19 articles
- C-Class Japan-related articles
- Low-importance Japan-related articles
- WikiProject Japan articles
- Wikipedia requested photographs in Japan
- Wikipedia requested logos